Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00187551 · ClinicalTrials.gov registry record · Phase 4

Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance

A Phase 4 study of HIV Infections, sponsored by University of California, San Francisco.

Completed
Registry status
Phase 4
Development phase
25
Enrollment target
1
Study location

NCT00187551 is a Phase 4 study of HIV Infections that has completed, run by University of California, San Francisco. The registered enrollment target is 25 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00187551, a Phase 4 study of HIV Infections, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
Phase 4
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to examine whether enfuvirtide (T20, Fuzeon) has continued anti-HIV activity in patients experiencing an incomplete virologic response to an enfuvirtide-based regimen.

Conditions Studied

HIV Infections

Interventions

  • OTHER Interruption of enfuvirtide
  • OTHER enfuvirtide interrupton

Study Locations (1)

California

  • San Francisco General Hospital - San Francisco

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2000-05
Est. Completion 2005-11
Phase Phase 4

Sponsor

University of California, San Francisco

1,713 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00187551

The ClinicalTrials.gov registry entry for NCT00187551 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (94% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Interruption of enfuvirtide is the first listed.

NCT00187551 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00187551 about?

NCT00187551 is a clinical study titled "Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance". The goal of this study is to examine whether enfuvirtide (T20, Fuzeon) has continued anti-HIV activity in patients experiencing an incomplete virologic response to an enfuvirtide-based regimen.

What is the current status of trial NCT00187551?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2000-05. Estimated completion is 2005-11.

What conditions does trial NCT00187551 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT00187551?

The interventions under investigation include: Interruption of enfuvirtide (OTHER), enfuvirtide interrupton (OTHER).

Who is sponsoring clinical trial NCT00187551?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00187551 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.